Assessment of symptoms, quality of life and associated costs in a one-month follow-up of cancer patients with breakthrough pain: The IMDI Study
<p>Purpose: Breakthrough Pain (BTP) observed in up to 66% of cancer patients, is more common in patients with advanced cancer stages and is usually associated with a poor prognosis.</p><p>The objective of this study was to evaluate the quality of life and control of associated symp...
Saved in:
Main Authors: | Concepción Pérez (Author), Antonio Javier Jiménez-López (Author), Almudena Sanz-Yagüe (Author), Begoña Soler-López (Author) |
---|---|
Format: | Book |
Published: |
Open Journal of Pain Medicine - Peertechz Publications,
2020-01-13.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Observational study to analyse the opioid titration process in the treatment of breakthrough pain of cancer patients in clinical practice
by: Lara Iglesias-Docampo, et al.
Published: (2019) -
Consensus statement on the management of breakthrough cancer pain: Assessment, treatment and monitoring recommendations
by: María Dolores López Alarcón, et al.
Published: (2019) -
IMDIS. A Teaching Tool for Air Pollution Dispersion Modelling
by: Salcedo, Romualdo
Published: (2020) -
Breakthroughs in Melanoma Research
Published: (2011) -
Breakthrough cancer pain: A delphi consensus study on expert recommendations for barriers that prevent the proper management of BTcP in Spain
by: Yolanda Escobar Álvarez, et al.
Published: (2020)